Advertisement
Interview: Zulfikar Abbany
This is the first UK study of ketamine in this way. Patients suffering from "treatment-resistant" depression received intravenous infusions under controlled conditions. The team has treated 45 patients - of whom, nine patients benefitted "to the point where it was thought worthwhile to have further intermittent ketamine treatments."